About the event

Held over a weekend, the event is structured around a series of exhibitions, workshops, and panel discussions. The exhibitions showcase a curated selection of photographs that tell compelling stories from various corners of the globe, each image accompanied by detailed narratives that provide context and deeper insight into the historical significance of the scenes depicted. These photographs are drawn from the archives of renowned photographers, as well as emerging talents, ensuring a blend of both classical and contemporary perspectives.

Cliff Palace, Colorado
Gaining Ground: Galmed Pharmaceuticals Ltd (GLMD) Closes Higher at 0.92, Up 12.40 – DwinneX

Gaining Ground: Galmed Pharmaceuticals Ltd (GLMD) Closes Higher at 0.92, Up 12.40

Nora Barnes

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

The price of Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) closed at $0.92 in the last session, up 12.40% from day before closing price of $0.82. In other words, the price has increased by $12.40 from its previous closing price. On the day, 0.26 million shares were traded. GLMD stock price reached its highest trading level at $0.9392 during the session, while it also had its lowest trading level at $0.81.

Ratios:

We take a closer look at GLMD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.98 and its Current Ratio is at 7.98. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In the most recent recommendation for the company, B. Riley FBR on May 22, 2020, Downgraded its rating to Neutral and sets its target price to $8 from $11 previously.

On February 04, 2020, Craig Hallum started tracking the stock assigning a Buy rating and target price of $18.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GLMD now has a Market Capitalization of 5061713 and an Enterprise Value of -15629042.

Stock Price History:

The Beta on a monthly basis for GLMD is 0.35, which has changed by -0.7125874 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, GLMD has reached a high of $3.61, while it has fallen to a 52-week low of $0.74. The 50-Day Moving Average of the stock is -29.48%, while the 200-Day Moving Average is calculated to be -41.73%.

Shares Statistics:

According to the various share statistics, GLMD traded on average about 2.00M shares per day over the past 3-months and 12426200 shares per day over the past 10 days. A total of 5.48M shares are outstanding, with a floating share count of 5.41M. Insiders hold about 1.19% of the company’s shares, while institutions hold 4.49% stake in the company. Shares short for GLMD as of 1763078400 were 1321 with a Short Ratio of 0.00, compared to 1760486400 on 19221. Therefore, it implies a Short% of Shares Outstanding of 1321 and a Short% of Float of 0.02.

Earnings Estimates

Its stock is currently analyzed by 1 different market analysts. Analysts are recommending an EPS of between -$2.31 and -$2.31 for the fiscal current year, implying an average EPS of -$2.31. EPS for the following year is -$0.85, with 1.0 analysts recommending between -$0.85 and -$0.85.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.